You can access the annual and quarterly cash flow statements of Autonomix Medical Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q4
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-36.10%-3.54M
-15.27%-2.89M
-29.03%-2.97M
-139.16%-3.82M
-40.60%-2.60M
-9.71%-2.51M
10.00%-2.30M
---1.60M
---1.85M
-268.63%-2.29M
-352.97%-2.56M
---620.40K
---564.43K
Net income from continuing operations
18.25%-2.73M
16.45%-2.67M
-20.20%-3.26M
-165.44%-7.45M
-23.64%-3.34M
40.99%-3.19M
12.85%-2.71M
---2.81M
---2.70M
-722.54%-5.41M
-471.61%-3.11M
---657.48K
---544.60K
Operating gains losses
0.00%3.00K
-93.75%3.00K
-91.49%4.00K
-95.56%2.00K
-93.02%3.00K
4.35%48.00K
34.29%47.00K
--45.00K
--43.00K
--46.00K
--35.00K
----
----
Other non-cash items
---1.79M
--0.00
--0.00
3859.41%4.00M
----
--0.00
--0.00
--101.00K
----
----
----
----
----
Change in working capital
182.75%967.00K
-200.44%-230.00K
639.62%286.00K
-181.45%-505.00K
-22.97%342.00K
211.17%229.00K
-140.62%-53.00K
--620.00K
--444.00K
-655.57%-206.00K
757.63%130.47K
--37.08K
---19.84K
-Change in other current assets
-13.10%73.00K
12.33%-320.00K
76.67%159.00K
-121.26%-27.00K
-81.66%84.00K
-3218.18%-365.00K
122.24%90.00K
--127.00K
--458.00K
-3989.22%-11.00K
-4596.29%-404.67K
---269.00
--9.00K
Cash from non-recurring investing activities
Cash from operating activities
-36.10%-3.54M
-15.27%-2.89M
-29.03%-2.97M
-139.16%-3.82M
-40.60%-2.60M
-9.71%-2.51M
10.00%-2.30M
---1.60M
---1.85M
-268.63%-2.29M
-352.97%-2.56M
---620.40K
---564.43K
Investing cash flow
Net cash from continuing investing activities
----
-25.00%3.00K
40.00%7.00K
--0.00
-100.00%0.00
33.33%4.00K
-68.75%5.00K
--0.00
--5.00K
--3.00K
--16.00K
----
----
Capital expenditures
----
-25.00%3.00K
40.00%7.00K
--0.00
-100.00%0.00
33.33%4.00K
-68.75%5.00K
--0.00
--5.00K
--3.00K
--16.00K
----
----
Net cash flow from disposal of fixed assets
----
-25.00%3.00K
40.00%7.00K
--0.00
-100.00%0.00
33.33%4.00K
-68.75%5.00K
--0.00
--5.00K
--3.00K
--16.00K
----
----
Net cash flow from other investing activities
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
----
25.00%-3.00K
-40.00%-7.00K
--0.00
100.00%0.00
-33.33%-4.00K
68.75%-5.00K
--0.00
---5.00K
---3.00K
---16.00K
----
----
Financing cash flow
Cash flow from continuous financing activities
-100.00%0.00
79.89%-35.00K
-39.46%5.43M
--2.71M
--2.06M
-101.80%-174.00K
445.53%8.97M
--0.00
--0.00
1334.07%9.68M
--1.65M
--675.00K
--0.00
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
-100.00%0.00
----
----
--0.00
--1.65M
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
-100.00%0.00
-100.00%0.00
-90.93%909.00K
--501.00K
--2.12M
-99.98%2.00K
--10.03M
--0.00
--0.00
1509.78%10.87M
--0.00
--675.00K
--0.00
Proceeds from issuance of warrants
----
---5.00K
400.00%5.00K
--2.55M
----
--0.00
--1.00K
----
----
----
----
----
----
Net cash flow from other financing activities
100.00%0.00
82.95%-30.00K
529.56%4.52M
---342.00K
---64.00K
85.16%-176.00K
-20940.00%-1.05M
--0.00
--0.00
---1.19M
---5.00K
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.00%0.00
79.89%-35.00K
-39.46%5.43M
--2.71M
--2.06M
-101.80%-174.00K
445.53%8.97M
--0.00
--0.00
1334.07%9.68M
--1.65M
--675.00K
--0.00
Net cash flow
Beginning cash balance
-23.34%7.00M
-15.98%9.93M
45.04%7.48M
27.23%8.59M
6.13%9.14M
870.69%11.82M
140.25%5.16M
--6.75M
--8.61M
-40.41%1.22M
56.12%2.15M
--2.04M
--1.37M
Current period cash flow changes
-547.90%-3.54M
-9.04%-2.93M
-63.15%2.46M
30.33%-1.11M
70.54%-547.00K
-136.36%-2.69M
818.76%6.67M
---1.60M
---1.86M
13434.30%7.39M
-64.36%-927.70K
--54.60K
---564.43K
Ending cash balance
-59.72%3.46M
-23.34%7.00M
-15.98%9.93M
45.04%7.48M
27.23%8.59M
6.13%9.14M
870.69%11.82M
--5.16M
--6.75M
310.17%8.61M
50.37%1.22M
--2.10M
--810.00K
Free cash flow
----
-15.20%-2.90M
-29.05%-2.98M
-139.16%-3.82M
-40.23%-2.60M
-9.74%-2.51M
10.37%-2.31M
---1.60M
---1.86M
---2.29M
---2.57M
----
----
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did Autonomix Medical Inc Generate?
Autonomix Medical Inc generated -12.28M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did Autonomix Medical Inc's Operating Cash Flow Change Year Over Year?
Autonomix Medical Inc's operating cash flow increased by -48.73% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
How Much Does Autonomix Medical Inc Spend on Capital Expenditures?
Autonomix Medical Inc spent 10.00K on capital expenditures in the most recent quarter。
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has Autonomix Medical Inc's Financing Cash Flow Changed?
Autonomix Medical Inc used 10.16M in financing activities in the latest quarter.
What is free cash flow and why does it matter for AMIX?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was Autonomix Medical Inc’s free cash flow in the latest quarter?
Free cash flow was -12.29M reflecting a -48.60% change from the previous year.